-
Acridine Orange hydrochloride: Practical Use Guide
2026-09-14
Acridine Orange hydrochloride provides membrane-permeable, differential fluorescence for nucleic acid staining, supporting cell cycle analysis, apoptosis detection, and flow-based DNA/RNA assessment. It is intended for nucleic acid workflows, not non-nucleic-acid targets, protocols requiring an impermeable dye, or long-term storage of working solutions.
-
Acridine Orange hydrochloride: Practical Guide
2026-09-14
Acridine Orange hydrochloride is a membrane-permeable fluorescent nucleic acid dye for differentiating DNA- and RNA-associated fluorescence in cytochemical and flow-based workflows. This guide covers solution preparation, instrument controls, cell cycle analysis, and apoptosis detection while clarifying that working concentrations, exposure times, and long-term solution stability require laboratory-specific validation.
-
Br-DAPI for Diabetic Cardiomyopathy DNA Imaging
2026-09-13
Br-DAPI extends nuclear imaging beyond simple visualization, providing a sensitive DNA quantification dye for live and fixed cardiomyocyte workflows. Paired with lipotoxicity, ER-stress, lipid-accumulation, and apoptosis assays, it helps researchers distinguish cell-loss artifacts from genuine mechanistic changes.
-
Vacuolin-1 as a Causal Probe of Lysosomal Exocytosis
2026-09-12
Vacuolin-1 is a lysosomal exocytosis inhibitor that helps separate lysosome-plasma membrane fusion from downstream growth-factor and repair phenotypes. This article translates recent MPS IVA findings into a rigorous assay strategy for secretion, membrane repair, and calcium-dependent trafficking studies.
-
EdU Imaging Kits (Cy3) for Organoid Assays
2026-09-11
EdU Imaging Kits (Cy3) translate DNA replication into bright, antibody-free Cy3 fluorescence for microscopy or flow cytometry. They are particularly useful for testing drug responses in patient-derived organoids where cancer-associated fibroblasts can change apparent proliferation and treatment sensitivity.
-
MK-4827 (Niraparib) Workflow for PARP Studies
2026-09-11
Build reproducible PARP inhibition assays with MK-4827 (Niraparib), from BRCA-mutant viability profiling to cisplatin-sequenced resistance models and radiosensitization studies. The workflow emphasizes solvent control, treatment timing, PARylation confirmation, and translation of recent ovarian cancer findings into practical assay design.
-
BCECF-AM for Intracellular pH Measurement
2026-09-10
BCECF-AM turns dynamic intracellular acid–base changes into a quantitative ratiometric readout for mammalian, plant, microbial, and yeast experiments. This guide connects practical loading and calibration choices with secretion biology, cytotoxicity workflows, and troubleshooting strategies that improve cross-sample comparability.
-
Exogenous NADH Reprograms E. tarda Antibiotic Killing
2026-09-10
The 2024 Virulence study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism and markedly improve the bactericidal activity of neomycin and related antibiotics. By connecting purine and energy metabolism with ATP-dependent antibiotic efficacy, the work presents metabolic enhancement as an adjunct strategy for resistant bacterial infections.
-
AZD8055 Workflow for Dual mTOR Inhibition
2026-09-09
AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer cell proliferation, and metabolic responses. It is best suited to preclinical cell and animal workflows, not aqueous formulations or conclusions about clinical efficacy.
-
BMS-345541 (free base): Assay Reliability Guide
2026-09-09
Learn how BMS-345541 (free base), SKU B4655, can strengthen cell viability, inflammation, and NF-κB pathway experiments through mechanism-aware controls and practical handling. This guide connects biochemical potency, cell-based assay design, formulation, and vendor-selection criteria to improve interpretation and reproducibility.
-
EdU Imaging Kits (HF594) for PDAC PNI
2026-09-08
EdU Imaging Kits (HF594) convert S-phase DNA synthesis into a quantitative red-fluorescence readout for pancreatic cancer–Schwann cell models. This article translates the reference study’s PGE2-driven perineural invasion findings into practical imaging, flow cytometry, optimization, and troubleshooting workflows.
-
SHC-1 Inhibition and CFTR Membrane Trafficking
2026-09-08
The 2026 Biochemical and Biophysical Research Communications study shows that MAPK/SHC-1-dependent CFTR internalization occurs across airway and intestinal epithelial models, but that pharmacological responses to SHC-1 inhibitors are strongly cell-context dependent. Its findings refine how researchers interpret CFTR trafficking assays and suggest that increased surface abundance should be distinguished from selective restoration of channel regulation.
-
SM-102 for Reliable mRNA-LNP Cell Assays
2026-09-07
Learn how SM-102 (SKU C1042) can improve the interpretability of cell viability, proliferation, and cytotoxicity workflows involving mRNA-loaded lipid nanoparticles. This scenario-based guide connects formulation identity, solvent compatibility, storage, controls, and vendor selection to evidence from recent mRNA delivery research.
-
XYD113: Selective GSPT1 Degradation in MYC Cancers
2026-09-07
The reference study identifies XYD113 as an orally active molecular glue degrader that selectively recruits CRBN to eliminate GSPT1 in MYC-driven cancer models. Its combination of sub-100 nM cellular antiproliferative activity, limited degradation of common glutarimide substrates, and xenograft efficacy supports further evaluation while leaving important translational questions unresolved.
-
Trelagliptin and PI-3K/AKT Signaling in Adipocytes
2026-09-05
The reference study shows that trelagliptin succinate can improve insulin resistance features in differentiated 3T3-L1 adipocytes by strengthening IRS-1/PI-3K/AKT signaling, GLUT4 membrane localization, and glucose uptake. Its findings extend the interpretation of DPP-4 inhibition beyond glycemic control by connecting trelagliptin with adipokine and lipid-related changes in an adipocyte model.